| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $211.0M | +239.0% |
| Cost of Revenue | $192.0M | +199.4% |
| Gross Profit | $19.0M | +1103.2% |
| R&D Expense | $65.2M | +56.0% |
| SG&A Expense | $89.0M | +52.5% |
| Operating Income | -$135.2M | -32.5% |
| Pre-tax Income | -$132.9M | -6.5% |
| Income Tax | $3.0M | +139.9% |
| Net Income | -$135.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $242.5M | -64.9% |
| Short-term Investments | $229.3M | — |
| Accounts Receivable | $36.6M | +162.0% |
| Inventory | $92.3M | +92.6% |
| Current Assets | $662.3M | -14.5% |
| Total Assets | $989.1M | +0.8% |
| Current Liabilities | $162.9M | +69.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$106.5M | -48.4% |
| Capital Expenditures | $42.4M | +65.0% |
| Investing Cash Flow | -$346.1M | -275.6% |
| Financing Cash Flow | $2.0M | -99.7% |
| Free Cash Flow | -$148.9M | -52.8% |
| -15.9% |
| EPS (Basic) | -$0.29 | +48.2% |
| EPS (Diluted) | -$0.29 | +48.2% |
| Long-term Debt |
| $100.0M |
| +2.8% |
| Total Liabilities | $315.9M | +11.9% |
| Stockholders' Equity | $673.2M | -3.6% |